Latest Breaking News On - Robert stanislaro - Page 1 : comparemela.com

Walden Biosciences Announces Research Collaboration with World Renowned Genetic Epidemiologist to Advance Work on Causal Role of suPAR in Chronic Kidney Disease

Walden Biosciences Announces Research Collaboration with World Renowned Genetic Epidemiologist to Advance Work on Causal Role of suPAR in Chronic Kidney Disease
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomHelen ogormanDipender gillRobert stanislaroWalden biosciencesBlaine mckeeAlex duncanWalden biosciences incWalden biosciences announces research collaborationPrimula groupImperial college londonBiosciences announces research collaborationWorld renowned genetic epidemiologistAdvance workCausal role

ProQR Announces First Quarter 2024 Operating and Financial Results

ProQR Announces First Quarter 2024 Operating and Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandRobert stanislaroSarah kielyPeter kelleherMartin maierEli lillyOwners of the companyProqr management teamCompany lillyEuropean patent officeExchange commissionCompany euroAlnylam pharmaceuticalsAnnual meetingAnnual general meeting

ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases

ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic Diseases
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesGerard platenburgRobert stanislaroEli lillySarah kielyPeter kelleherAmerican society of gene cell therapyCompany axiomerEditing program targetingProqr management teamExchange commissionPreclinical proofConcept dataProgram targetingAmerican societyCell therapy

ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2024 ProQR Therapeutics NV. , a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™.

Noord hollandBart filiusPeter kelleherAjames shannonMartin maierSarah kielyGerard platenburgTheresa heggieDinko valerioErnst bayerRobert stanislaroAlison lawtonIonis pharmaceuticalsAllen overyCorporate developmentAlnylam pharmaceuticals

ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 ProQR Therapeutics NV , a company dedicated to changing lives through transformative RNA therapies, today announced it will present new.

United statesSarah kielyGerard platenburgPeter kelleherEli lillyRobert stanislaroAmerican society of gene cell therapyExchange commissionAmerican societyCell therapyAnnual meetingChief scientific officerEditing oligonucleotidesConjugated editing oligonucleotideAdenosine deaminase actingLooking statements